Merck
  • Home
  • Search Results
  • Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model.

Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model.

International journal of pharmaceutics (2015-01-18)
Joonho Bae, Jin Woo Park
ABSTRACT

We prepared an injectable depot system for the long-term delivery of alendronate using a solid/water/oil/water multiple emulsion technique with poly(lactic-co-glycolic acid) as a carrier. The microparticles were spherical with smooth surfaces, ranging from 20 to 70 μm in size. The microspheres (ALD-HA-RG504H-MC70) were optimally prepared by introducing a viscous material (hyaluronic acid) and a co-solvent system in the inner aqueous and oil phases, respectively, and showed a significantly increased drug encapsulation efficacy (>70%); the initial burst release was <10% after 1 day. In vitro drug release from ALD-HA-RG504H-MC70 followed zero-order kinetics for approximately 4 weeks and the alendronate plasma level was maintained for more than 1 month after intramuscular injection in rabbits. The ovariectomized (OVX) rats with ALD-HA-RG504H-MC70 injected intramuscularly (0.9 mg alendronate/kg/4 weeks) had 112% and 482% increased bone mineral density and trabecular area in the tibia than the OVX controls, respectively, and showed significant improvements in trabecular microarchitecture and bone strength. Furthermore, the major biomarkers of bone turnover revealed that ALD-HA-RG504H-MC70 suppressed effectively the progression of osteoporosis and facilitated new bone formation. Therefore, this sustained release depot system may improve patient compliance and therapeutic efficacy by reducing dose amounts and frequency with minimal adverse reactions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Fmoc chloride, BioReagent, ≥99.0% (HPLC)
Sigma-Aldrich
DL-Lactic acid, ~90% (T)
Supelco
Fmoc chloride, for HPLC derivatization, LiChropur, ≥99.0% (HPLC)
Sigma-Aldrich
Fmoc chloride, 97%
Sigma-Aldrich
DL-Lactic acid, 85 % (w/w), syrup
Sigma-Aldrich
Lactic acid solution, ACS reagent, ≥85%
Sigma-Aldrich
Lactic acid solution, Vetec, reagent grade, 85%
Sigma-Aldrich
Lactic acid, meets USP testing specifications
Sigma-Aldrich
Glycolic acid, BioXtra, ≥98.0% (titration)
Sigma-Aldrich
Lactic acid, 85%, FCC
Sigma-Aldrich
Glycolic acid solution, technical grade, 70 wt. % in H2O
Sigma-Aldrich
Lactic acid, natural, ≥85%
Sigma-Aldrich
Glycolic acid, ReagentPlus®, 99%
Sigma-Aldrich
Glycolic acid solution, high purity, 70 wt. % in H2O
USP
Lactic acid, United States Pharmacopeia (USP) Reference Standard
Supelco
Glycolic acid, certified reference material, TraceCERT®
Sigma-Aldrich
Edelfosine, ≥95% (HPLC)
Supelco
Lactic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Glycolic Acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glycolic acid, Vetec, reagent grade, 98%